Jocelyn Star Gandelman

Jocelyn Gandelman practices at Schweiger Dermatology in New York, New York.

Jocelyn Gandelman's NPI, 1841753472, was assigned on April 10, 2019. Jocelyn Gandelman graduated from Vanderbilt University School Of Medicine in 2019. Jocelyn Gandelman holds New York license 320905.

Jocelyn Gandelman's primary practice is Schweiger Dermatology, at 137 W 96th St, New York, NY 10025 in New York County. The practice phone is (929) 470-5354.

Jocelyn Gandelman's primary practice is Schweiger Dermatology in New York, New York. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Jocelyn Gandelman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jocelyn Gandelman practices. Vendor and product names are available with a free account.

Dermatology is Jocelyn Gandelman's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Jocelyn Gandelman is licensed in New York.

CMS data shows 912 Medicare services from Jocelyn Gandelman across 11 procedure codes in 2024, for 180 Medicare patients. Medicare paid $53,059 for them. Every service was in an office.

CMS counts 180 Medicare patients who saw Jocelyn Gandelman in 2024. The largest group is 65 to 74, with 96 patients. 74% of them have high cholesterol, and 51% have high blood pressure. 10% are also on Medicaid. Their average risk score is 0.78, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jocelyn Gandelman's median patient age at 40, with 66% women.

In 2024, Jocelyn Gandelman wrote 700 Medicare Part D claims for 163 patients. 87% of them were for generic drugs. CMS names the drug for 548 of them, across 17 drugs with 11 or more claims each, at $118,690 in total drug cost. In 2023, CMS named 93 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Jocelyn Gandelman for performance year 2024, reported as part of a group. Jocelyn Gandelman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 435 procedures of removal of skin lesions by Jocelyn Gandelman, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Jocelyn Gandelman, published from 2018 to 2024. 2018 was the busiest year, with 10. The most frequent topics are Graft vs Host Disease, Dermatology and Hematopoietic Stem Cell Transplantation. Jocelyn Gandelman has published most often in Bone Marrow Transplant. Jocelyn Gandelman's most frequent co-authors are Madan Harikishin Jagasia, MD, Eric Tkaczyk, MD, PhD and April Lynn Barnado, MD.

CMS Open Payments shows 346 general payments to Jocelyn Gandelman from 27 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 82% of the total. Eli Lilly and Company paid the most, $2,151.

Jocelyn Gandelman graduated from Vanderbilt University School Of Medicine in 2019.